Close Menu

The first trial using CRISPR within the human body is to begin this fall to treat a form of blindness, according to the Associated Press.

Editas Medicine and Allergan plan to enroll 18 people with Leber congenital amaurosis, a genetic form of blindness that affects the retina, in their study. According to the AP, Leber congenital amaurosis is the most common cause of inherited childhood blindness.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New research shows that scientists need to do a better job of including a wider diversity of African genomes in their analyses, STAT says.

A new paper in Science shows that men are still winning a large majority of the most sought-after NIH grants.

Nature Research and the Estée Lauder Companies are awarding efforts to encourage girls to pursue careers in the STEM fields.

In Science this week: beneficial genetic variants inherited from archaic Neanderthal and Denisovan hominins, and more.